The National Institute of Health and Care Excellence (NICE) – the drugs advisory body to the National Health Service (NHS) in the UK – has criticized Roche Holding Ltd. (ADR) (RHHBY) over its refusal to cut prices for Kadcyla, which is used to treat severe cases of breast cancer. Kadcyla is approved to treat HER2-positive breast cancer that has spread to other parts of the body and cannot be surgically removed. Roche’s US-based partner, Immunogen Inc. (IMGN) said that the drug holds a 43% market share in the US. The drug contributed about 0.5% or $252.6 million to the company’s overall revenues in FY13. ImmunoGen, Inc. (NASDAQ:IMGN) belongs to Healthcare sector. Its weekly performance is 2.60%. On last trading day company shares ended up $11.82. ImmunoGen, Inc. (NASDAQ:IMGN) distance from 50-day simple moving average (SMA50) is 2.72%.

The “Guardians of the Galaxy” misfits reached a new box office stratosphere over the U.S. Labor Day weekend, soaring past fellow Marvel hero “Captain America” to become the highest-grossing domestic movie of 2014. “Guardians” has earned $547.7 million around the globe, distributor Walt Disney Co said. The Walt Disney Company (NYSE:DIS) shares moved down -0.39% in last trading session and ended the day at $89.88. DIS Gross Margin is 23.60% and its return on assets is 8.90%. The Walt Disney Company (NYSE:DIS) quarterly performance is 6.66%.

UOL BoaCompra, the leader in digital goods payments in emerging markets, and Shanda Games International Europe, a Germany-based publisher of online and mobile games, today announced a partnership to monetize and market the popular free-to-play action MMORPG Dragon Nest Europe in Brazil. On 29 August, Shanda Games Limited (NASDAQ:GAME) shares increased 0.16% and was closed at $6.43. GAME EPS growth in last 5 year was 11.80%. Shanda Games Limited (NASDAQ:GAME) year to date (YTD) performance is 40.39%.

EQT Midstream Partners, LP (NYSE: EQM) has been on the move lately as the stock has risen by 10% in the past four weeks, and it is currently trading well above its 20-Day SMA. The stock currently has a Zacks Rank #1 (Strong Buy), suggesting that the recent run could certainly continue for this in-focus company. EQT Midstream Partners, LP (NYSE:EQM) ended the last trading day at $97.49. Company weekly volatility is calculated as 2.87%and price to cash ratio as 234.92. EQT Midstream Partners, LP (NYSE:EQM) showed a weekly performance of 5.76%.

President & CEO of Northeast Bancorp (NBN) Richard Wayne bought 12,618 shares on 08/18/2014 at an average price of $9.55. Total transaction amount is $120,502. Northeast Bancorp (NASDAQ:NBN) shares moved down -0.11% in last trading session and ended the day on $9.42. NBN return on assets is 0.30%. Northeast Bancorp (NASDAQ:NBN) quarterly performance is -2.79%.